Cannabis trial approved
February 29, 2016
NEW South Wales Premier
Mike Baird announced a new
medical cannabis trial on Friday for
chemotherapy patients who are
suffering from nausea.
With 330 patients set to take part,
it’s the largest trial of its kind and
the third to ever take place in the
state.
Baird’s announcement follows
changes to the Narcotic Drugs Act
passed in the Senate last Wed,
allowing medical marijuana to
be grown and manufactured in
Australia (PD 25 Feb 16).
During the trial, which is
expected to start mid 2016, an
oral cannabis-derived capsule
containing tetrahydrocannabinol
and cannabidiol will be used.
The drug has been developed
and supplied by Tilray, a Canadian
medicinal cannabis company.
“Medicinal cannabis has the
potential to be of incredible benefit
to many and our clinical trials will
help us provide relief to those
suffering from a range of serious
illnesses,” Baird said in an official
statement.
“Everyone knows someone
who has been affected by cancer
and this third trial will assess
what role medicinal cannabis can
play in controlling nausea and
vomiting in patients undergoing
chemotherapy”.
The previous trials of this kind
were for terminally ill patients and
children with severe epilepsy, and
these trials will pave the way for
making such treatments available
to whomever needs it, he said.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Feb 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Feb 16
